Microba Life Sciences (ASX:MAP) Cash Payments : A$-37.61 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Cash Payments?

Microba Life Sciences's Cash Payments for the six months ended in Dec. 2024 was A$-18.06 Mil.

Microba Life Sciences's Cash Payments for the trailing twelve months (TTM) ended in Dec. 2024 was A$-37.61 Mil.

Microba Life Sciences Cash Payments Historical Data

The historical data trend for Microba Life Sciences's Cash Payments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Cash Payments Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

Jun24

Cash Payments

-17.84

-22.22

-35.30

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash Payments	Get a 7-Day Free Trial			-10.09	-12.13	-15.75	-19.55	-18.06

Microba Life Sciences Cash Payments Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Payments represents cash flow paid from operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Payments" section for non-financial companies:
Payments to Suppliers for Goods and Services
Payments on Behalf of Employees
Other Cash Payments from Operating Activities

Cash Payments for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-37.61 Mil.

Microba Life Sciences Cash Payments Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Cash Payments provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Cash Payments

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are; Testing Services and Supplements which derives key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.

Microba Life Sciences Headlines

No Headlines